Completion Pancreatectomy After Pancreatoduodenectomy

医学 胰瘘 外科 围手术期 胰腺切除术 胰十二指肠切除术 胰腺炎 急性胰腺炎 吻合 瘘管 并发症 坏死性胰腺炎 普通外科 胰腺 切除术 内科学
作者
Martin Loos,Anna‐Katharina König,Nikolai von Winkler,Arianeb Mehrabi,Christoph Berchtold,Beat P. Müller‐Stich,Martin Schneider,Katrin Hoffmann,Yakup Kulu,Manuel Feißt,Ulf Hinz,Matthias Lang,Benjamin Goeppert,Thomas Albrecht,Oliver Strobel,Markus W. Büchler,Thilo Hackert
出处
期刊:Annals of Surgery [Ovid Technologies (Wolters Kluwer)]
卷期号:278 (1): e87-e93 被引量:13
标识
DOI:10.1097/sla.0000000000005494
摘要

The objective of this study was to identify the indications for and report the outcomes of completion pancreatectomy (CPLP) in the postoperative course after pancreatoduodenectomy (PD).CPLP may be considered or even inevitable for damage control after PD.A prospectively maintained database of all patients undergoing PD between 2001 and 2019 was searched for patients who underwent CPLP in the postoperative course after PD. Baseline characteristics, perioperative details, and outcomes of CPLP patients were analyzed and specific indications for CPLP were identified.A total of 3953 consecutive patients underwent PD during the observation period. CPLP was performed in 120 patients (3%) after a median of 10 days following PD. The main indications for CPLP included postpancreatectomy acute necrotizing pancreatitis [n=47 (39%)] and postoperative pancreatic fistula complicated by hemorrhage [n=41 (34%)] or associated with uncontrollable leakage of the pancreatoenteric anastomosis [n=23 (19%)]. The overall 90-day mortality rate of all 3953 patients was 3.5% and 37% for patients undergoing CPLP.Our finding that only very few patients (3%) need CPLP suggests that conservative, interventional, and organ-preserving surgical measures are the mainstay of complication management after PD. Postpancreatectomy acute necrotizing pancreatitis, uncontrollable postoperative pancreatic fistula, and fistula-associated hemorrhage are highly dangerous and represent the main indications for CPLP after PD.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
luoxiyysgt发布了新的文献求助30
1秒前
munire发布了新的文献求助10
1秒前
1秒前
搜集达人应助MY采纳,获得10
2秒前
认真的冷菱应助小美美采纳,获得10
2秒前
2秒前
liu完成签到,获得积分10
2秒前
一川完成签到,获得积分10
2秒前
寒冷的迎梦完成签到,获得积分10
4秒前
儒飞发布了新的文献求助10
4秒前
4秒前
5秒前
李健应助科研通管家采纳,获得10
5秒前
星辰大海应助科研通管家采纳,获得10
5秒前
酷波er应助科研通管家采纳,获得10
5秒前
orixero应助科研通管家采纳,获得10
5秒前
gyh应助科研通管家采纳,获得10
5秒前
ding应助科研通管家采纳,获得10
5秒前
小二郎应助科研通管家采纳,获得10
5秒前
我是老大应助科研通管家采纳,获得10
5秒前
5秒前
5秒前
诃子应助科研通管家采纳,获得10
5秒前
震动的鹏飞完成签到 ,获得积分10
5秒前
慕青应助科研通管家采纳,获得10
5秒前
5秒前
JamesPei应助科研通管家采纳,获得10
6秒前
6秒前
Whc发布了新的文献求助10
6秒前
丘比特应助科研通管家采纳,获得10
6秒前
互助应助科研通管家采纳,获得20
6秒前
6秒前
lian发布了新的文献求助10
6秒前
大模型应助科研通管家采纳,获得10
6秒前
6秒前
6秒前
6秒前
打打应助科研通管家采纳,获得10
6秒前
领导范儿应助科研通管家采纳,获得10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 2000
Digital Twins of Advanced Materials Processing 2000
晋绥日报合订本24册(影印本1986年)【1940年9月–1949年5月】 1000
Social Cognition: Understanding People and Events 1000
Polymorphism and polytypism in crystals 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6032860
求助须知:如何正确求助?哪些是违规求助? 7724235
关于积分的说明 16202007
捐赠科研通 5179593
什么是DOI,文献DOI怎么找? 2771901
邀请新用户注册赠送积分活动 1755195
关于科研通互助平台的介绍 1640075